In a USA study, the odds of receiving treatment with a GLP-1 RA were higher in individuals with diabetes who had a high household income compared to those with an annual income of less than US$50,000, and these findings were consistent in a subgroup analysis comprising solely participants with established cardiovascular disease [21]. Here, GLP1R is linked to diabetes mellitus.